Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
Summary: The new generation, i.e., second- and third-generation, drug-eluting stents (DESs) remain a risk of in-stent restenosis (ISR). We evaluated the power of a genetic risk score (GRS) model to identify high-risk populations for new generation DES ISR. We enrolled patients with coronary artery d...
Main Authors: | Yen-Wen Liu, Mu-Shiang Huang, Ling-Wei Hsu, Hsien-Yuan Chang, Cheng-Han Lee, Chi-Ying Lee, Dao-Peng Chen, Yi-Heng Li, Ting-Hsin Chao, Pei-Fang Su, Meng-Ru Shen, Ping-Yen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221010506 |
Similar Items
-
Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01) -
Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
by: Violeta Dinesch, et al.
Published: (2017-04-01) -
Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01) -
Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Published: (2017-04-01) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01)